subscribeSubscribe
Sosei Announces Submission of New Drug Application in Japan for Daridorexant

Sosei Announces Submission of New Drug Application in Japan for Daridorexant
GLOBENEWSWIRE
31 Oct 2023
Share Share
Idorsia announces its insomnia medication, QUVIVIQ, is now covered by CVS

Idorsia announces its insomnia medication, QUVIVIQ, is now covered by CVS
PR NEWSWIRE
10 Jul 2023
Share Share
Idorsia launches QUVIVIQ (daridorexant) in Switzerland

Idorsia launches QUVIVIQ (daridorexant) in Switzerland
GLOBENEWSWIRE
12 Jun 2023
Share Share
Idorsia notes potential $440.8M Asia licensing deal to extend cash runway

Idorsia notes potential $440.8M Asia licensing deal to extend cash runway
Katherine Lewin ENDPTS
06 Jun 2023
Share Share
Idorsia Announces Support for a Trial being Conducted by the U.S. Dept QUVIVIQ

Idorsia Announces Support for a Trial being Conducted by the U.S. Dept QUVIVIQ
PR NEWSWIRE
10 May 2023
Share Share
Idorsia`s insomnia drug enters clinic as a treatment for PTSD

Idorsia`s insomnia drug enters clinic as a treatment for PTSD
Kevin Dunleavy FIERCE PHARMA
10 May 2023
Share Share
Health Canada approves QUVIVIQ forthe management of adult patients with insomnia

Health Canada approves QUVIVIQ forthe management of adult patients with insomnia
GLOBENEWSWIRE
03 May 2023
Share Share
Idorsia requests to de-schedule DORA insomnia drugs

Idorsia requests to de-schedule DORA insomnia drugs
Kevin Dunleavy FIERCE PHARMA
08 Apr 2023
Share Share
2022 drug approvals: Biopharma delivered 37 new drugs

2022 drug approvals: Biopharma delivered 37 new drugs
Kevin Dunleavy FIERCE PHARMA
03 Jan 2023
Share Share
Roche: Changes in the Board of Directors and the Corporate Executive Committee

Roche: Changes in the Board of Directors and the Corporate Executive Committee
GLOBENEWSWIRE
12 Dec 2022
Share Share